Stimulated by the relatively high frequency of TBC1D24 variants in the ADHL cohort, we focused on molecular aspects of detected TBC1D24 variants and clinical features of the TBC1D24-related HL. Here, TBC1D24 is linked to Hodgkins lymphoma.